• C-Peptide
  • Myeloid Differentiation Primary Response 88 (MYD88) Gene Mutation Analysis
  • Pepsin A
  • 6-Monoacetylmorphine (6-MAM) Confirmation, Meconium
  • Chromosome Analysis, Solid Tumors
  • IKBKAP (Inhibitor of Kappa Light Polypeptide Gene Enhancer in B-cells, Kinase Complex-associated Protein) Gene Mutation Analysis
  • Factor H Complement Antigen
  • Leptin
  • Circulating Tumor Cells (CTC), Colon Cancer
  • Newborn Aneuploidy Detection, FISH
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Methodology
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.
Loading...